The National Lung Screening Trial: Results stratified by demographics, smoking history, and lung cancer histology

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|22|3976-3983

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.22, 2013-11, pp. : 3976-3983

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of lung cancer screening results on participant health‐related quality of life and state anxiety in the National Lung Screening Trial

By  

CANCER, Vol. 120, Iss. 21, 2014-11 ,pp. : 3401-3409

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stratified Treatment in Lung Cancer

By  

Oncology Research and Treatment, Vol. 39, Iss. 12, 2016-11 ,pp. : 760-766

Karger

Access to resources Recommend Favorite

Benefit of Erlotinib in Patients with Non-Small-Cell Lung Cancer Is Related to Smoking Status, Gender, Skin Rash and Radiological Response but Not to Histology and Treatment Line

By  

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 249-258

Karger

Access to resources Recommend Favorite

Benefits and Risks of Lung Cancer Screening

By  

Oncology Research and Treatment, Vol. 37, Iss. 3, 2014-08 ,pp. : 58-66

Karger

Access to resources Recommend Favorite

Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening

By  

CANCER, Vol. 121, Iss. 24, 2015-12 ,pp. : 4341-4347

John Wiley & Sons Inc

Access to resources Recommend Favorite